Welcome to The E-Cigarette Summit USA 2017
The inaugural holding of the US E-Cigarette Summit will take place at The Marriott Georgetown, in Washington, DC, on Monday, May 8, 2017.
Awareness of e-cigarettes is high among the public, but there is debate among experts and officials about whether e-cigarettes provide an opportunity to move smokers away from inhaling tobacco smoke or are a menace that will attract those not already using tobacco products. The US Summit will feature expert presentations on current data regarding population patterns of use among youth and adults, results regarding performance, toxicity, and utility of e-cigarettes for smoking cessation and reduction, and the public health impacts surrounding youth initiation and progression as well as impacts on adult smoking behaviour.
The organizers of this conference have held four annual Summits in London relying upon a similar format and will bring their disciplined, careful, and balanced approach to the US in hopes of better understanding differing views and the foundations underpinning those perspectives. The London E-Cigarette Summit has established itself as a neutral environment for scientists, policy makers, medical and public health professionals, and e-cigarette stakeholders to come together and look critically at the latest scientific research and evidence available on e-cigarettes and then debate their impact in the context of public health and regulation.
The E-Cigarette Summit will feature extensive discussion on the opportunity for comprehensive regulation, principally product regulation at the national level to minimize negative consequences and realize benefits. Presenters will discuss the difficulty of finding “sweet spot” of regulation where public health is improved optimally by minimizing premature death and disease as rapidly as possible while protecting nonusers and remaining responsive to a tobacco control manifesto.
The role that e-cigarettes could play in ending or extending the smoking epidemic is likely to remain one of the most fiercely fought debates in public health history. We cannot answer every question yet, but we believe that progress is not only possible but imperative. These first important steps to regulate an entirely novel product category will set the agenda for decades to come and is likely to be viewed as a pivotal era in both tobacco control and combustible tobacco use in the future.
What questions will be explored?
The E-Cigarette Summit will include high level briefings from experts and encourages interaction through panel debates and open floor discussions. Questions will be explored in a balanced and objective environment allowing attendees to build their knowledge and share their viewpoints. The E-Cigarette Summit will explore the latest research and evidence on the following areas:
- What do we know about patterns of use of all tobacco and nicotine products and what key questions remain?
- What does the available research indicate about the relative and absolute health consequences of the use of the range of tobacco and nicotine products?
- How do alternative tobacco and nicotine products impact established tobacco control policies, programs, and regulations?
- What can the experience of other countries teach about regulation of these products?
- What areas of agreement and common ground exist even amidst the debate?
- What are the principles of public health policy and regulation that should shape the future of these products?
- What are the values-based questions that need to be answered to move this debate towards resolution or at least refinement and focus?
Who Should Attend?
The E-Cigarette Summit will provide a timely and interactive opportunity for all stakeholders to debate and explore the future of e-cigarettes and the broader issues raised by nicotine without smoke, and will include high-level panel debates from opposing perspectives to ensure a balanced and objective debate.
In particular, this event will be relevant to:
- Regulators and policy advisors
- Health providers and public health advocates
- National, state and local legislators and their staffs
- Public health professionals
- Scientific/research community
- Medical and health professionals
- e-cigarette industry stakeholders